Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2007
10/31/2007EP1755606B1 Quinazolinone derivatives useful as vanilloid antagonists
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN101065386A Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
10/31/2007CN101065364A Novel pyrimidine derivatives and their use as PPAR-alpha modulators
10/31/2007CN101065359A Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
10/31/2007CN101062928A Process for preparing 2-pyrrolidinyl-1h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
10/31/2007CN101062053A Reduced toxicity cisplatin formulations and methods for using the same
10/31/2007CN100345853C Pyrazolopyrimidine compound and method for producing the same
10/31/2007CN100345850C Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345830C Condensed heteroaryl derivatives
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/30/2007US7288655 α v integrin receptor antagonists
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/30/2007US7288546 Reacting protein with 5-{5-(2-nitro-phenyl)-furan-2-ylmethylene}-1,3-diphenyl-2-thioxo-dihydropyrimidine-4,6-dione
10/30/2007US7288544 Calcium channel antagonistic activity; especially useful as analgesics
10/30/2007US7288543 Opioid receptor antagonists
10/30/2007US7288540 Phenylalkynes
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/25/2007WO2007121280A1 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
10/25/2007WO2007120669A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis
10/25/2007WO2007120593A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007WO2007120339A1 Pyrimidine kinase inhibitors
10/25/2007WO2007119771A1 Test agent for diagnosing dyspepsia
10/25/2007WO2007119361A1 Method for production of quinazolin-4-on derivative
10/25/2007WO2007119085A1 Rosuvastatin zinc salt
10/25/2007WO2007119055A1 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
10/25/2007WO2007118859A1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
10/25/2007WO2007098352A3 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
10/25/2007WO2006033844A9 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators
10/25/2007US20070249831 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia
10/25/2007US20070249830 Reference standard for characterization of rosuvastatin
10/25/2007US20070249641 Adenosine a3 receptor modulators
10/25/2007US20070249636 Selected Fused Heterocyclics and Uses Thereof
10/25/2007US20070249632 Pharmaceutical compositions and use thereof
10/25/2007US20070249631 e.g. 3 fluoro N [6 (4 fluoro benzoyl)5,6,7,8 tetrahydro pyrido[4,3 d]pyrimidin 2yl]benzamide; analgesics; neuropathic pain; side effect reduction
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249617 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders
10/25/2007US20070249605 such as methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetate
10/25/2007US20070249604 3-Monosubstituted tropane derivatives as nociceptin receptor ligands
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/25/2007US20070249548 Nucleoside Analog or Salts of the Same
10/25/2007US20070249031 Aminopyrimidines useful as kinase inhibitors
10/25/2007CA2649302A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007CA2649262A1 Test agent for diagnosing dyspepsia
10/25/2007CA2649219A1 Rosuvastatin zinc salt
10/25/2007CA2648543A1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
10/25/2007CA2648216A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis
10/25/2007CA2648202A1 Compositions useful as inhibitors of voltage-gated sodium channels
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1846399A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
10/24/2007EP1846392A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
10/24/2007EP1845993A2 Novel adenosine a3 receptor modulators
10/24/2007EP1845991A2 Substituted 5-phenyl pyrimidines i in therapy
10/24/2007EP1567010B1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
10/24/2007EP1505980B1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
10/24/2007EP1112743B1 Nitrogenous heterocyclic carboxamide derivatives or salt thereof as antiviral agents
10/24/2007CN100344630C Process for preparing 2-pyrrolidinyl-3h,5h-pyrrolo[3,2-d]pyrimidine -4-ketone derivative
10/24/2007CN100344615C Production of N-(pyrrolo[2,3-d] pyrimidine-5-) acyl glusate derivative and intermediate
10/24/2007CN100344612C Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285558 Helicobacter infections; bactericides
10/23/2007US7285557 For therapy of obesity, diabetes, depression, or anxiety in a mammal
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007CA2217780C Polyether nucleic acids
10/18/2007WO2007117607A2 Quinazolines for pdk1 inhibition
10/18/2007WO2007117161A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007WO2007117009A1 2,2-dialkoxyethylamine compound and method for producing same
10/18/2007WO2007116412A1 Substituted pyrimidines, process for their production and their use as effective absorbents of uv irradiation
10/18/2007WO2007116374A1 Novel sulfonamide compounds
10/18/2007WO2007116314A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007WO2007093870A3 A process for the preparation of risperidone
10/18/2007WO2007060691B1 A novel process for the preparation of erlotinib
10/18/2007WO2006117358A9 New heterocyclylethylamide derivatives
10/18/2007WO2006114409A9 Pyrimidines reacting with o6-alkylguanine-dna alkyltransferase
10/18/2007US20070244323 Pharmaceutical Compositions Comprising Zd6474
10/18/2007US20070244321 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244140 Anilino-pyrimidine phenyl and benzothiophene analogs
10/18/2007US20070244138 antiinflammatory agents
10/18/2007US20070244136 Quinazoline Derivatives
10/18/2007US20070244133 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine
10/18/2007US20070244132 Fused Heterocyclic Compound
10/18/2007US20070244131 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
10/18/2007US20070244116 c-MET MODULATORS AND METHOD OF USE
10/18/2007US20070244114 Compounds and therapeutical use thereof
10/18/2007US20070244113 Compounds and therapeutical use thereof
10/18/2007US20070244111 Pyrazolopyrimidines
10/18/2007US20070244098 Dual Small Molecule Inhibitors of Cancer and Angiogenesis
10/18/2007DE69233686T2 Heteoaryl-Piperidine und Piperazine und ihre Anwendung als antipsychotisches und analgetisches Mittel Heteoaryl-piperidines and piperazines and their use as antipsychotic and analgesic agent
10/18/2007CA2648978A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007CA2648529A1 Quinazolines for pdk1 inhibition
10/18/2007CA2648323A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007CA2646917A1 Novel sulfonamide compounds
10/17/2007EP1845092A1 Pyrimidinone compounds, their preparation and use thereof
10/17/2007EP1844794A1 Silicon implants comprising a radionucleotide and/or a cytotoxic drug and their use in cancer treatment
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 427